This document is a financial appendix page (marked CONFIDENTIAL) bearing a House Oversight Bates stamp (HOUSE_OVERSIGHT_024103). It details the investment performance of 'Sprout Capital VIII, L.P. (Healthcare Technology Portfolio)' as of March 31, 2014. It lists specific investments in healthcare and technology companies (such as Charles River Laboratories and eHealth, Inc.), showing the vintage year (ranging from 1998-2000), total cost, realized value, and internal rate of return (IRR) for each.
This document is a confidential financial schedule for 'Sprout Capital IX, L.P. (Healthcare Technology Portfolio)' as of March 31, 2014. It details realized and unrealized investments in numerous healthcare and biotechnology companies, listing vintage years, costs, realized values, and IRRs. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of a congressional investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity